Use of implantable cardioverter-defibrillators for primary prevention in older patients: A systematic literature review and meta-analysis
Author(s) -
Melissa H. Kong,
Sana M. AlKhatib,
Gillian D Sanders,
Vic Hasselblad,
Eric D. Peterson
Publication year - 2011
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.2011.0005
Subject(s) - medicine , meta analysis , randomized controlled trial , clinical endpoint , implantable cardioverter defibrillator , observational study , sudden cardiac death , medline , primary prevention , disease , political science , law
Randomized clinical trials (RCTs) have demonstrated the efficacy of implantable cardioverter-defibrillators (ICDs) in reducing sudden cardiac death (SCD) in specific patient populations. However, patients ≥ 65 years were under-represented in these trials and the overall benefit of ICDs may be diminished in older patients due to competing risks for death. We evaluate the published data on ICD efficacy at reducing all-cause mortality in patients ≥ 65 years and in patients ≥ 75 years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom